Exercise-induced Bronchoconstriction
📧 Sign up to get email alerts when something new happens for Exercise-induced Bronchoconstriction.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-11-08FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved Ajanta Pharma USA Inc.'s supplemental application for montelukast sodium.
-
FDA approval · 2019-11-08FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Ajanta Pharma USA Inc.)
The FDA approved Ajanta Pharma USA Inc.'s supplemental application for Montelukast Sodium, enabling the generic montelukast product (ANDA 20…
-
FDA approval · 2019-11-08FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approves Ajanta Pharma USA Inc.'s supplemental application for Montelukast Sodium, updating regulatory status for the product.
-
FDA approval · 2019-11-07FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare's supplemental application for montelukast sodium under ANDA202717, resulting in an updated approved product.…
-
FDA approval · 2019-11-05FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental ANDA for montelukast sodium from Rising Pharma Holdings, enabling the marketing of a generic montelukast sodium …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-11-05FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for Montelukast Sodium from Rising Pharma Holdings, Inc., enabling a generic product entry. This dec…
-
FDA approval · 2019-08-09FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast sodium) submitted by Organon LLC.
-
FDA approval · 2019-08-09FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast) by Organon LLC, marking an additional regulatory action for the product.
-
FDA approval · 2019-08-09FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for Singulair (montelukast sodium) submitted by Organon LLC.
-
CLINICAL_TRIALS research · 2019-01-29Clinical Trial Update: Mediator Release During Exercise-induced Bronchoconstriction [NA]
Brunel University reports an update on a clinical trial examining mediator release during exercise-induced bronchoconstriction (exercise-ind…
-
FDA approval · 2018-12-21FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application to the Singulair (montelukast) NDA submitted by Organon LLC.
-
FDA approval · 2018-12-21FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast) submitted by Organon LLC.
-
FDA approval · 2018-07-31FDA Approved: MONTELUKAST SODIUM — Original Application (Torrent Pharmaceuticals Limited)
FDA approves Torrent Pharmaceuticals Limited's original ANDA for montelukast sodium (generic montelukast).
-
FDA approval · 2018-07-30FDA Approved: MONTELUKAST — Supplemental Application (XLCare Pharmaceuticals Inc.)
FDA approved a supplemental application for montelukast from XLCare Pharmaceuticals Inc. under ANDA 202843.
-
FDA approval · 2018-07-23FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for Montelukast Sodium from Rising Pharma Holdings, Inc., enabling the marketing of the generic prod…
-
FDA approval · 2018-07-02FDA Approved: MONTELUKAST SODIUM — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved the original ANDA for montelukast sodium from Unichem Pharmaceuticals (USA), Inc., establishing a generic version of this asthm…
-
FDA approval · 2018-05-18FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare Inc.'s supplemental application for Montelukast Sodium.
-
FDA approval · 2018-05-18FDA Approved: MONTELUKAST — Supplemental Application (BluePoint Laboratories)
The FDA approved a supplemental application for montelukast submitted by BluePoint Laboratories under ANDA 203366. The decision denotes appr…
-
CLINICAL_TRIALS trial_result · 2017-10-31Clinical Trial Update: The Effect of Benralizumab on Exercise-induced Bronchoconstriction [Phase 3]
This is an update on a Phase 3 trial evaluating benralizumab for exercise-induced bronchoconstriction in asthma, with the trial status curre…
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: Relative Bioavailability Study of Two Montelukast Sodium (GW483100) 5 Milligrams (mg) Chewable Tablets and One Reference Montelukast Sodium 5 mg Chewable Tablet in Healthy Adult Subjects [Phase 1]
A Phase 1 relative bioavailability study comparing two Montelukast sodium 5 mg chewable tablets to a reference 5 mg Montelukast chewable tab…
-
FDA approval · 2017-04-24FDA Approved: MONTELUKAST SODIUM — Original Application (Rising Pharma Holdings, Inc.)
The FDA approved a generic Montelukast Sodium product from Rising Pharma Holdings, Inc. under an Original Application (ANDA209012). It provi…
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: Exercise-induced Bronchoconstriction Diagnostics: Impact of a Repeated Exercise Challenge Test
A completed clinical trial examined the diagnostic impact of repeating an exercise challenge test for exercise-induced bronchoconstriction.
-
FDA label_change · 2016-12-13FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast sodium) by Organon LLC, resulting in updated labeling for the product.
-
CLINICAL_TRIALS trial_result · 2016-09-05Clinical Trial Update: Bronchial Inflammation and Hyperresponsiveness After Oil Supplementation [NA]
A completed clinical trial from Johann Wolfgang Goethe University Hospital evaluated whether oil supplementation influences bronchial inflam…
-
FDA approval · 2016-06-23FDA Approved: MONTELUKAST — Supplemental Application (BluePoint Laboratories)
The FDA approved a supplemental application for Montelukast from BluePoint Laboratories.